Michael Gerg

USPTO Granted Patents = 24 (Patent Applications = 20)

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 17 (Patent Applications = 16)

Average Co-Inventor Count = 5.7

ph-index = 3

Forward Citations = 23(Granted Patents)

Company Filing History:

12 out of 1,648

Roche Diagnostics Operations, Inc.

patents

11 out of 4,942

Hoffmann-la Roche Inc.

patents

1 out of 514

Ventana Medical Systems, Inc.

patents

4. 1 out of 621

Roche Molecular Systems, Inc.

patents

where one patent can have more than one assignee

Years Active: 2013-2025

where 'Filed Patents' based on already Granted Patents

24 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12360108 - Biotin-specific monoclonal antibody and use thereof (2025-07-15),

2. 12351647 - Binding agent and assay for PIVKA (2025-07-08),

3. 12158466 - Method for determining the total amount and/or concentration of an analyte in the presence of a binding molecule as well as kits, compositions and uses relating thereto (2024-12-03),

4. 12025613 - Biotin-specific monoclonal antibody and use thereof (2024-07-02),

5. 11618790 - Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery (2023-04-04),

6. 11466098 - Binding agent and assay for PIVKA (2022-10-11),

7. 11415576 - Method for measurement of vitamin D (2022-08-16),

8. 10982007 - Detection of a posttranslationally modified polypeptide by a bivalent binding agent (2021-04-20),

9. 10808038 - HER3/HER2 bispecific antibodies binding to the beta-hairpin of HER3 and domain II of HER2 (2020-10-20),

10. 10647765 - Amino acid sequence presenting fusion polypeptide and its use (2020-05-12),

11. 10626177 - HER3 antigen binding proteins binding to the beta-hairpin of HER3 (2020-04-21),

12. 10564151 - Method for determining the total amount and/or concentration of an analyte in the presence of a binding molecule as well as kits, compositions and uses relating thereto (2020-02-18),

13. 10364290 - Anti-HER3/HER4 antibodies binding to the beta-hairpin of HER3 and the beta-hairpin of HER4 (2019-07-30),

14. 10301383 - Antibody specifically binding to insulin-like growth factor-1 (2019-05-28),

15. 10179815 - Antibodies specifically binding to HER3 (2019-01-15),

Title: Michael Gerg: Pioneering Innovations in Munich.

Introduction:

Michael Gerg, a visionary inventor based in Munich, Germany, is renowned for his remarkable contributions to the world of inventions. With a total of 21 patents to his name, Gerg's inventive spirit and commitment to technological advancement have solidified his position as a true pioneer in the field.

Latest Patents:

1. Biotin-specific monoclonal antibody and use thereof: Gerg's groundbreaking invention revolves around a monoclonal antibody capable of binding to biotin. This antibody plays a crucial role in measuring analytes in samples using a (strept)avidin/biotin pair for specific binding.

2. Polypeptide-polynucleotide-complex for targeted effector moiety delivery: Another innovative creation by Gerg is a therapeutic polypeptide-polynucleotide-complex designed for targeted delivery of an effector moiety. This complex remains resistant to degradation in vivo and binds specifically to target compounds, tissues, or organs.

Career Highlights:

Throughout his career, Michael Gerg has made significant contributions to renowned companies such as Hoffmann-La Roche Inc. and Roche Diagnostics Operations, Inc. His innovative solutions and inventive mindset have left a lasting impact on the companies he has been associated with, shaping the landscape of innovation within these organizations.

Collaborations:

Gerg's collaborative efforts with industry experts such as Michael Schraeml and Christian Scholz have further enriched his innovative journey. By working alongside talented individuals, Gerg has been able to push the boundaries of traditional thinking and bring revolutionary ideas to fruition.

Conclusion:

In conclusion, Michael Gerg's relentless pursuit of innovation and his commitment to creating a better future through technology make him a true pioneer in the world of inventions. His remarkable contributions continue to inspire the next generation of inventors and shape the landscape of innovation for years to come.

This text is generated by artificial intelligence and may not be accurate.